Hoffmann La Roche Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOFFMANN LA ROCHE, and what generic alternatives to HOFFMANN LA ROCHE drugs are available?
HOFFMANN LA ROCHE has ten approved drugs.
There are six US patents protecting HOFFMANN LA ROCHE drugs.
There are one hundred and eighty patent family members on HOFFMANN LA ROCHE drugs in forty-six countries and twenty-three supplementary protection certificates in seventeen countries.
Summary for Hoffmann La Roche
| International Patents: | 180 |
| US Patents: | 6 |
| Tradenames: | 9 |
| Ingredients: | 8 |
| NDAs: | 10 |
Drugs and US Patents for Hoffmann La Roche
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann La Roche | ROCEPHIN | ceftriaxone sodium | INJECTABLE;INJECTION | 063239-001 | Aug 13, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Hoffmann La Roche | ACCUTANE | isotretinoin | CAPSULE;ORAL | 018662-003 | May 7, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Hoffmann La Roche | BONIVA | ibandronate sodium | TABLET;ORAL | 021455-002 | Mar 24, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hoffmann La Roche
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Hoffmann La Roche | FORTOVASE | saquinavir | CAPSULE;ORAL | 020828-001 | Nov 7, 1997 | 6,352,717*PED | ⤷ Try a Trial |
| Hoffmann La Roche | ACCUTANE | isotretinoin | CAPSULE;ORAL | 018662-004 | Mar 28, 1983 | 4,322,438 | ⤷ Try a Trial |
| Hoffmann La Roche | ROMAZICON | flumazenil | INJECTABLE;INJECTION | 020073-001 | Dec 20, 1991 | 4,316,839 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HOFFMANN LA ROCHE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 1 mg/mL, 3 mL Vial | ➤ Subscribe | 2007-08-31 |
| ➤ Subscribe | Tablets | 2.5 mg and 150 mg | ➤ Subscribe | 2007-05-16 |
International Patents for Hoffmann La Roche Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 101440257 | ⤷ Try a Trial |
| Uruguay | 32540 | ⤷ Try a Trial |
| China | 101223169 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hoffmann La Roche Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1893612 | C20120016 00059 | Estonia | ⤷ Try a Trial | PRODUCT NAME: ZELBORAF - VEMURAFENIIB;REG NO/DATE: C(2012)1180 FINAL 17.02.2012 |
| 0432695 | 96C0044 | Belgium | ⤷ Try a Trial | PRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004 |
| 1893612 | 122 5012-2012 | Slovakia | ⤷ Try a Trial | FIRST REGISTRATION NO/DATE: EU/1/12/751/001, 20120217 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
